Clinical trial

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469

Study summary

ClinicalTrials.gov

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention GSK189075 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-17

PhasePHASE2

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

GSK189075DRUG

PlaceboDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

BerlinGermany4 Las VegasNevada, United States4 HoustonTexas, United States3 KaunasLithuania3 DallasTexas, United States2 AtlantaGeorgia, United States2 MiamiFlorida, United States2 TorontoOntario, Canada2 PragueCzechia2 AthensGreece2 ThessalonikiGreece2 BrnoCzechia2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00495469 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.